As part of Pink October, Breast Cancer Awareness Month, we would like to highlight the importance of prevention, screening and patient care.
As a pharmacovigilance service provider, we contribute every day to an essential objective: ensuring patient safety and continuously assessing and improving the benefit-risk balance of medicines.
In the context of breast cancer treatments, monitoring and evaluating adverse reactions play a major role. Collecting, analysing and evaluating safety data helps us better understand the risks associated with treatments and contributes to making patient care safer.
🎀In October, just as throughout the year, every signal matters, every piece of data matters, and every patient matters.
Because health is a shared responsibility, let’s continue working toward better prevention and safer care.
